Results 1 to 10 of about 7,157 (115)

Crystal structure of pirfenidone (5-methyl-1-phenyl-1H-pyridin-2-one): an active pharmaceutical ingredient (API) [PDF]

open access: yesActa Crystallographica Section E: Crystallographic Communications, 2019
The crystal structure of pirfenidone, C12H11NO [alternative name: 5-methyl-1-phenylpyridin-2(1H)-one], an active pharmaceutical ingredient (API) approved in Europe and Japan for the treatment of Idiopathic pulmonary fibrosis (IPF), is reported here for ...
Mauro Barbero   +4 more
doaj   +4 more sources

Promoting local production and active pharmaceutical ingredient (API) industry in low and middle income countries (LMICs): impact on medicines access and policy [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
The success of universal coverage depends on ensuring that patients have access to medicine. Encouraging local production of medicines in developing countries can provide better access to medicines.
Muhammad Akhtar Abbas Khan, Asim Rauf
doaj   +4 more sources

Active pharmaceutical ingredient (API) chemicals: a critical review of current biotechnological approaches. [PDF]

open access: yesBioengineered, 2022
Kumar V   +7 more
europepmc   +2 more sources

Brazilian national production of active pharmaceutical ingredients: regulatory and strategic framework

open access: yesAnais da Academia Brasileira de Ciências, 2023
Active Pharmaceutical Ingredient (API) is any component of the final pharmaceutical product that serves as the active ingredient. The goal of the API Manufacturing is to produce APIs that are competitively priced and meet the quality standards with the ...
MARLON DANIEL L. TONINI   +2 more
doaj   +1 more source

Chemometrics-Assisted UV-Vis Spectrophotometry for Quality Control of Pharmaceuticals: A Review

open access: yesIndonesian Journal of Chemistry, 2023
Spectroscopic method in the UV-Vis region is considered the most molecular spectrometric method for content determination of a single component. However, a lot of pharmaceutical dosage forms comprise two or more components which lead to peak overlapping.
Laela Hayu Nurani   +6 more
doaj   +1 more source

Selecting the most appropriate formulation excipient for manufacture of amorphous solid dispersions: a case study of lumefantrine

open access: yesBritish Journal of Pharmacy, 2022
This work demonstrated the importance of pre-formulation studies and proposed a generalised scheme for excipient screening in the early stage of amorphous solid dispersion(ASD) system development by profiling the excipients’ capability to solubilise ...
Dijia Liu   +3 more
doaj   +1 more source

Monitoring of Pentoxifylline Thermal Behavior by Novel Simultaneous Laboratory Small and Wide X-Ray Scattering (SWAXS) and Differential Scanning Calorimetry (DSC). [PDF]

open access: yesPLoS ONE, 2016
The thermal and structural evolutions associated to active pharmaceutical ingredient (API) purity are monitored using a laboratory instrument (S3-MicroCaliX) allowing simultaneous time-resolved X-ray scattering at both wide and small angles (SWAXS) as a ...
Aden Hodzic   +3 more
doaj   +1 more source

Measuring Bismuth Oxide Particle Size and Morphology in Film-Coated Tablets

open access: yesMolecules, 2022
The assessment of active pharmaceutical ingredient (API) particle size and morphology is of great importance for the pharmaceutical industry since it is expected to significantly affect physicochemical properties.
Stefani Fertaki   +3 more
doaj   +1 more source

Light-sensitive medicinal compounds – the actual review of studies and strategies in proceedings [PDF]

open access: yesFarmacja Polska, 2019
The main procedure for stability testing of Active Pharmaceutical Ingredients (API) and medicinal products is described in the guidelines of the International Council for the Harmonization of Technical Requirements for Human Drugs (ICH).
Marzena Jamrógiewicz   +2 more
doaj   +1 more source

Fast Initiating Furan-Containing Hoveyda-Type Complexes: Synthesis and Applications in Metathesis Reactions

open access: yesChemistry, 2022
Two new ruthenium complexes with chelating-ether benzylidene ligands bearing a furan moiety were synthesized and characterized, including X-ray crystallography.
Maryana Nadirova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy